News Releases

Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference

Dec 30, 2016

MARLBOROUGH, Mass., Dec. 30, 2016 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco.

Mike Mahoney, chairman and chief executive officer, will present at approximately 7:30 a.m. PST. At 8:00 a.m., Mike will be joined by Dan Brennan, executive vice president and chief financial officer, Ian Meredith, AM, Ph.D., global chief medical officer and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with audience members.

A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Tom Keppeler

Susie Lisa, CFA

508-683-6585 (office)

508- 683-5565 (office)

Corporate Communications

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

tom.keppeler@bsci.com

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation